Deutsches Herzzentrum Muenchen

Quick facts

Marketed products

• Abciximab + UFH · Cardiovascular
  Abciximab is a monoclonal antibody that blocks platelet glycoprotein IIb/IIIa receptors to prevent platelet aggregation, combined with unfractionated heparin (UFH) for anticoagulation during percutaneous coronary intervention.
• Abrupt Clopidogrel Interruption
• Clopidogrel Tapering · Cardiovascular
  Clopidogrel tapering is a dosing strategy that gradually reduces clopidogrel exposure after dual antiplatelet therapy to assess safety and efficacy of de-escalation in cardiovascular patients.
• Iomeprol 350
• oral anticoagulation
• ORSIRO · Other
• Un-fractionated heparin · Cardiovascular
  Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.

Phase 2 pipeline

• Pacemaker and defibrillator

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Deutsches Herzzentrum Muenchen portfolio CI brief
• Deutsches Herzzentrum Muenchen pipeline updates RSS